Hey boslo. Who knows what goes on in the privacy of one's home, but we are testing on the iPPS v. placebo in the trials, to establish iPPS on it's own merits. I get your drift, but these tests must be kept on a strict schedule of only what the test calls for, to gain FDA approval. Maybe it will, but I am not certain that it has been discussed much on these threads. Adding nsaids to the testing cold add another two/three years to approval....for each one! Hope that helps somewhat.
research reports and media, page-1154
-
- There are more pages in this discussion • 3,275 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $70.04M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.3¢ | 19.5¢ | $114.5K | 576.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 134949 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 100609 | 9 |
View Market Depth
| Last trade - 11.52am 07/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |